Advertisement

Topics

Latest "McKissock Hoffman" News Stories

17:15 EDT 24th April 2018 | BioPortfolio

Here are the most relevant search results for "McKissock Hoffman" found in our extensive news archives from over 250 global news sources.

More Information about McKissock Hoffman on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about McKissock Hoffman for you to read. Along with our medical data and news we also list McKissock Hoffman Clinical Trials, which are updated daily. BioPortfolio also has a large database of McKissock Hoffman Companies for you to search.

Showing "McKissock Hoffman" News Articles 1–25 of 42

Relevant

John Oliver Calls Out Dustin Hoffman to His Face Over Groping Accusations

John Oliver and Dustin Hoffman got into a heated exchange regarding the sexual harassment allegations leveled at the actor during a panel discussion Monday night at a benefit event for the Tribeca Film Institute.


Dustin Hoffman Allegedly Exposed Himself To A Minor, Assaulted 2 Women

Dustin Hoffman faces major accusations in a Variety report published Friday that alleges he exposed himself to a 16-year-old classmate of his daughter’s in 1980 and assaulted two other women while working on 1987′s “Ishtar.”

Paratek Appoints Rolf K. Hoffman to Company’s Board of Directors

-- Led U.S. and International Commercial Operations at Amgen Inc.--   BOSTON, April 13, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, today announced the appointment on April 11, 2018 of Rolf K. Hoffman, a global biopharmaceutical ...


Aerpio Pharmaceuticals Announces Inducement Grants

Aerpio Pharmaceuticals, Inc. (OTCQB: ARPO) (“Aerpio”), a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, announced today the grant of inducement equity awards to its newly appointed Chief Executive Officer, Stephen Hoffman, M.D., Ph.D., and its newly appointed Chief Financial Officer, Michael Rogers. The ...

Aerpio Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference

Aerpio Pharmaceuticals, Inc. (OTCQB: ARPO), a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, today announced that Chief Executive Officer, Stephen Hoffman, M.D., Ph.D., will present at the 17th Annual Needham Healthcare Conference on Tuesday, March 27, 2018 at 3:00 p.m. Eastern Time in New York, NY. Dr. Hoffm...

Aerpio Pharmaceuticals to Present at the Cowen 38th Annual Health Care Conference

Aerpio Pharmaceuticals, Inc. (OTCQB: ARPO), a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, today announced that Chief Executive Officer, Stephen Hoffman, M.D., Ph.D., will present at the Cowen 38th Annual Health Care Conference on Monday, March 12, 2018 at 2:50 p.m. Eastern Time in Boston, MA. Dr. Hoffman w...

Sears Holdings Reports Fourth Quarter And Full Year 2017 Results

HOFFMAN ESTATES, Ill., March 14, 2018/PRNewswire/ -- Sears Holdings Corporation ("Holdings," "we," "us," "our," or the "Company") (NASDAQ: SHLD) today announced financial results Read more...

Sears Holdings axes 64 Kmart stores in latest round of closings

David SalazarThe Hoffman Estates, Ill.-based company said that the stores would begin liquidation sales as early as January 12, with the first round of closings beginning in early March, continuing through early April. read more

Goldman stärkt Privatkundengeschäft und kauft Startup Clarity Money

Von Liz Hoffman und Peter Rudegeair NEW YORK (Dow Jones)--Die US-Bank Goldman Sachs stärkt ihr Privatkundengeschäft und kauft das Startup Clarity Money. Finanzielle Einzelheiten nannte Goldman zur...

Strategic partnership will apply organ-chips to drug efficacy and safety

A strategic partnership has been formed between scientists from Emulate and Roche (F Hoffman La-Roche) for the application of organ-chips in the testing of the efficacy and safety of new antibody therapeutics and combination therapies.

Probably Relevant

Monthly News Roundup - May 2017

Actemra: First Drug Approved to Treat Giant Cell Arteritis Actemra (tocilizumab) from Hoffman La Roche has gained a new indication as the first drug approved to treat adults with giant cell arteritis, a specific type of vasculitis. Vasculitis is...

Treatment of Giant Cell Arteritis With Tocilizumab: A Historical Perspective

I am thrilled to have Gary S. Hoffman, MD, MS, MACR, write this month’s Guest Editorial for Healio Rheumatology. No one, in my judgment, is better qualified to help us consider how the recent advances in giant cell arteritis will ultimately effect the way we treat the disease and, of course, ultimately how our patients can potentially benefit from these changes. New therapies must be critically ...

Mediaplanet Highlights the Importance of a Good Night’s Sleep

The Mediaplanet Sleep campaign aims to educate individuals on the importance of a good night’s sleep. NEW YORK (PRWEB) April 18, 2018 Mediaplanet’s latest edition of the "Sleep Solutions" campaign published both online and as an insert within USA Today, aims to educate individuals on the importance of a good night’s sleep. The print component of the campaign was distributed within...

Ex-FDA Official has Added New Material to ComplianceOnline Seminar on Post-Market Compliance: Complaint Handling, MDRs, Recalls and Proposed Guidance on FDA Risk Benefits

ComplianceOnline, the leading GRC advisory network, and Former FDA CDRH Recall Branch Chief, Rita Hoffman, will conduct one and a half day seminar on Navigating the Maze for Post-Market Compliance -- Complaint Handling, MDRs, Recalls and Proposed Guidance on FDA Risk Benefits. Palo Alto, CA, USA (PRWEB) November 14, 2017 New course materials have been added by Former FDA CDRH Recall Branch Chief ...

Preeclampsia, lactation duration affect CV risk in women

ORLANDO, Fla. — Two new studies presented at the American College of Cardiology Scientific Session highlight differences in CV risk related to preeclampsia history and lactation duration.The data in women highlight a need for increased awareness and research on women during pregnancy and postpartum.“This is an exciting and interesting topic within women’s cardiovascular health,” Karlee Hof...

20152023 World Mineral Feed Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 01022018] Prices from USD $2800

SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.Market Segment as follows:By Region / Countries North America U.S., Canada, Mexico Europe Germany, U.K., France, Italy, Russia, Spain etc South Americ...

Global Mineral Feed Market Research Report 2018 [Report Updated: 04012018] Prices from USD $3500

SummaryMarket Segment as follows:By Region AsiaPacific North America Europe South America Middle East AfricaBy Type Macro Minerals Micro MineralsBy Application Macro Minerals Micro MineralsBy Company Cargill Archer Daniels Midland Royal DSM Bluestar Adisseo Alltech Purina BASF Mole Valley Farmers Kent Feeds Kay Dee Feed Nutrena Lonza ...

Possibly Relevant

Acticor Biotech Announces Appointment of Dr Yannick Plétan as Chief Medical Officer

Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including stroke and other thrombosis disorders like pulmonary embolism, announces today the appointment of Dr Yannick Plétan as Chief Medical Officer. He will report to Gilles Avenard, CEO of Acticor Biotech and be responsible for leading all clini...

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Ohr Pharmaceutical, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Ohr Pharmaceutical, Inc. (Nasdaq: OHRP) (“Ohr” or the “Company”) securities during the period between June 24, 2...

AntiCancer Inc. Has Developed a Methuselah Enzyme Taken Orally That Hopefully Extends Normal Lifespan and Also Arrests Cancer

The common amino-acid methionine, present in all proteins, is a culprit in the aging process as well as in cancer. It is well known that dietary restriction of methionine can greatly extend a healthy life-span, and even reverse aspects of aging, as well as eradicate cancer in animal models. However, methionine-restricted diets cause unacceptable weight los...

Beaird Dermatology Kicks Off “We Want to See You Naked” Campaign, Focused on Skin Cancer Screening and Treatment

Chicago Area Billboard Brings Attention-Getting Directive to Encourage Consumer Skin Checks at www.skincheck.us Beaird Dermatology, led by Dr. Leslie Beaird, has initiated a Chicago area campaign, “We Want to See You Naked”, designed to raise community awareness for “head to toe” skin exams, an important screening that identifies prec...

NY Top Docs & NY Top Dentists Proudly Present March 2018 Approved Providers

NY Top Docs and NY Top Dentists are proud to feature the following March 2018 approved providers. SCOTCH PLAINS, N.J. (PRWEB) April 07, 2018 NY Top Docs and NY Top Dentists are proud to feature the following March 2018 approved providers. NY Top Docs Include: Allergy, Asthma & Immunology Dr. Yasmin Bhasin Dr. Peter M Deane Cardiology Dr. Emad Aziz Dr. Paul Bakere Dr. Jeffrey Bernste...

Startup World Cup Features Top Global Tech Leaders at $1,000,000 Competition in San Francisco on May 11

“Grand Finale” Brings Together Startup Founders From 30 Regional Competitions Across Six Continents Startup World Cup today announced the speakers and judges for the Startup World Cup 2018 Global Grand Finale, to be held at S

DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Antares Pharma, Inc. To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Antares Pharma, Inc. (Nasdaq: ATRS) (“Antares” or the “Company”) securities during the period between December 21, 2016 ...

Aerpio Reports Third Quarter 2017 Financial Results

Strengthened Senior Leadership Team with the Appointment of Stephen Hoffman, M.D., Ph.D., as Chief Executive Officer Effective December 1, 2017 TIME-2b Clinical Trial of AKB-9778 in Patients with Diabetic Retinopathy Remains on Track Aerpio Pharmaceuticals, Inc. (OTCQB:ARPO), a biopharmaceutical company focused on advancing first-in-cla...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks